Vincerx Pharma earnings missed, revenue was in line with estimates

  • Investing.com
Vincerx Pharma earnings missed, revenue was in line with estimates

Investing.com - Vincerx Pharma (NASDAQ: VINC ) reported first quarter EPS of $-0.46, worse than the analyst estimate of $-0.46. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.

Vincerx Pharma's stock price closed at $0.88. It is up 6.02% in the last 3 months and up 7.74% in the last 12 months.

Vincerx Pharma saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Vincerx Pharma's stock price’s past reactions to earnings here.

According to InvestingPro, Vincerx Pharma's Financial Health score is "fair performance".

Check out Vincerx Pharma's recent earnings performance , and Vincerx Pharma's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles